Medical Care
Global Imbruvica Market Research Report 2024
- Jan 26, 24
- ID: 25042
- Pages: 61
- Figures: 116
- Views: 28
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
The global Imbruvica market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Imbruvica in Mantle Cell Lymphoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Imbruvica include AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech) and SP Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Imbruvica, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imbruvica.
Report Scope
The Imbruvica market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imbruvica market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imbruvica companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
Segment by Type
5 mg
10 mg
140 mg
Segment by Application
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imbruvica companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Imbruvica market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Imbruvica in Mantle Cell Lymphoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Imbruvica include AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech) and SP Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Imbruvica, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imbruvica.
Report Scope
The Imbruvica market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imbruvica market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imbruvica companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
Segment by Type
5 mg
10 mg
140 mg
Segment by Application
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imbruvica companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imbruvica Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 5 mg
1.2.3 10 mg
1.2.4 140 mg
1.3 Market by Application
1.3.1 Global Imbruvica Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Waldenström's Macroglobulinemia
1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imbruvica Market Perspective (2019-2030)
2.2 Imbruvica Growth Trends by Region
2.2.1 Global Imbruvica Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Imbruvica Historic Market Size by Region (2019-2024)
2.2.3 Imbruvica Forecasted Market Size by Region (2025-2030)
2.3 Imbruvica Market Dynamics
2.3.1 Imbruvica Industry Trends
2.3.2 Imbruvica Market Drivers
2.3.3 Imbruvica Market Challenges
2.3.4 Imbruvica Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imbruvica Players by Revenue
3.1.1 Global Top Imbruvica Players by Revenue (2019-2024)
3.1.2 Global Imbruvica Revenue Market Share by Players (2019-2024)
3.2 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imbruvica Revenue
3.4 Global Imbruvica Market Concentration Ratio
3.4.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2023
3.5 Imbruvica Key Players Head office and Area Served
3.6 Key Players Imbruvica Product Solution and Service
3.7 Date of Enter into Imbruvica Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imbruvica Breakdown Data by Type
4.1 Global Imbruvica Historic Market Size by Type (2019-2024)
4.2 Global Imbruvica Forecasted Market Size by Type (2025-2030)
5 Imbruvica Breakdown Data by Application
5.1 Global Imbruvica Historic Market Size by Application (2019-2024)
5.2 Global Imbruvica Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Imbruvica Market Size (2019-2030)
6.2 North America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Imbruvica Market Size by Country (2019-2024)
6.4 North America Imbruvica Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imbruvica Market Size (2019-2030)
7.2 Europe Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Imbruvica Market Size by Country (2019-2024)
7.4 Europe Imbruvica Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imbruvica Market Size (2019-2030)
8.2 Asia-Pacific Imbruvica Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Imbruvica Market Size by Region (2019-2024)
8.4 Asia-Pacific Imbruvica Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imbruvica Market Size (2019-2030)
9.2 Latin America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Imbruvica Market Size by Country (2019-2024)
9.4 Latin America Imbruvica Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imbruvica Market Size (2019-2030)
10.2 Middle East & Africa Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Imbruvica Market Size by Country (2019-2024)
10.4 Middle East & Africa Imbruvica Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie (Pharmacyclics)
11.1.1 AbbVie (Pharmacyclics) Company Detail
11.1.2 AbbVie (Pharmacyclics) Business Overview
11.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction
11.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024)
11.1.5 AbbVie (Pharmacyclics) Recent Development
11.2 Johnson & Johnson (Janssen Biotech)
11.2.1 Johnson & Johnson (Janssen Biotech) Company Detail
11.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
11.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction
11.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024)
11.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
11.3 SP Laboratories
11.3.1 SP Laboratories Company Detail
11.3.2 SP Laboratories Business Overview
11.3.3 SP Laboratories Imbruvica Introduction
11.3.4 SP Laboratories Revenue in Imbruvica Business (2019-2024)
11.3.5 SP Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imbruvica Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 5 mg
1.2.3 10 mg
1.2.4 140 mg
1.3 Market by Application
1.3.1 Global Imbruvica Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Waldenström's Macroglobulinemia
1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imbruvica Market Perspective (2019-2030)
2.2 Imbruvica Growth Trends by Region
2.2.1 Global Imbruvica Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Imbruvica Historic Market Size by Region (2019-2024)
2.2.3 Imbruvica Forecasted Market Size by Region (2025-2030)
2.3 Imbruvica Market Dynamics
2.3.1 Imbruvica Industry Trends
2.3.2 Imbruvica Market Drivers
2.3.3 Imbruvica Market Challenges
2.3.4 Imbruvica Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imbruvica Players by Revenue
3.1.1 Global Top Imbruvica Players by Revenue (2019-2024)
3.1.2 Global Imbruvica Revenue Market Share by Players (2019-2024)
3.2 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imbruvica Revenue
3.4 Global Imbruvica Market Concentration Ratio
3.4.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2023
3.5 Imbruvica Key Players Head office and Area Served
3.6 Key Players Imbruvica Product Solution and Service
3.7 Date of Enter into Imbruvica Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imbruvica Breakdown Data by Type
4.1 Global Imbruvica Historic Market Size by Type (2019-2024)
4.2 Global Imbruvica Forecasted Market Size by Type (2025-2030)
5 Imbruvica Breakdown Data by Application
5.1 Global Imbruvica Historic Market Size by Application (2019-2024)
5.2 Global Imbruvica Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Imbruvica Market Size (2019-2030)
6.2 North America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Imbruvica Market Size by Country (2019-2024)
6.4 North America Imbruvica Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imbruvica Market Size (2019-2030)
7.2 Europe Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Imbruvica Market Size by Country (2019-2024)
7.4 Europe Imbruvica Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imbruvica Market Size (2019-2030)
8.2 Asia-Pacific Imbruvica Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Imbruvica Market Size by Region (2019-2024)
8.4 Asia-Pacific Imbruvica Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imbruvica Market Size (2019-2030)
9.2 Latin America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Imbruvica Market Size by Country (2019-2024)
9.4 Latin America Imbruvica Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imbruvica Market Size (2019-2030)
10.2 Middle East & Africa Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Imbruvica Market Size by Country (2019-2024)
10.4 Middle East & Africa Imbruvica Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie (Pharmacyclics)
11.1.1 AbbVie (Pharmacyclics) Company Detail
11.1.2 AbbVie (Pharmacyclics) Business Overview
11.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction
11.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024)
11.1.5 AbbVie (Pharmacyclics) Recent Development
11.2 Johnson & Johnson (Janssen Biotech)
11.2.1 Johnson & Johnson (Janssen Biotech) Company Detail
11.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
11.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction
11.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024)
11.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
11.3 SP Laboratories
11.3.1 SP Laboratories Company Detail
11.3.2 SP Laboratories Business Overview
11.3.3 SP Laboratories Imbruvica Introduction
11.3.4 SP Laboratories Revenue in Imbruvica Business (2019-2024)
11.3.5 SP Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Imbruvica Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 5 mg
Table 3. Key Players of 10 mg
Table 4. Key Players of 140 mg
Table 5. Global Imbruvica Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Imbruvica Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Imbruvica Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Imbruvica Market Share by Region (2019-2024)
Table 9. Global Imbruvica Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Imbruvica Market Share by Region (2025-2030)
Table 11. Imbruvica Market Trends
Table 12. Imbruvica Market Drivers
Table 13. Imbruvica Market Challenges
Table 14. Imbruvica Market Restraints
Table 15. Global Imbruvica Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Imbruvica Market Share by Players (2019-2024)
Table 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
Table 18. Ranking of Global Top Imbruvica Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Imbruvica Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Imbruvica Product Solution and Service
Table 22. Date of Enter into Imbruvica Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Imbruvica Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Imbruvica Revenue Market Share by Type (2019-2024)
Table 26. Global Imbruvica Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Imbruvica Revenue Market Share by Type (2025-2030)
Table 28. Global Imbruvica Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Imbruvica Revenue Market Share by Application (2019-2024)
Table 30. Global Imbruvica Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Imbruvica Revenue Market Share by Application (2025-2030)
Table 32. North America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Imbruvica Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Imbruvica Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Imbruvica Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 47. AbbVie (Pharmacyclics) Company Detail
Table 48. AbbVie (Pharmacyclics) Business Overview
Table 49. AbbVie (Pharmacyclics) Imbruvica Product
Table 50. AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 51. AbbVie (Pharmacyclics) Recent Development
Table 52. Johnson & Johnson (Janssen Biotech) Company Detail
Table 53. Johnson & Johnson (Janssen Biotech) Business Overview
Table 54. Johnson & Johnson (Janssen Biotech) Imbruvica Product
Table 55. Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson (Janssen Biotech) Recent Development
Table 57. SP Laboratories Company Detail
Table 58. SP Laboratories Business Overview
Table 59. SP Laboratories Imbruvica Product
Table 60. SP Laboratories Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 61. SP Laboratories Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imbruvica Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Imbruvica Market Share by Type: 2023 VS 2030
Figure 3. 5 mg Features
Figure 4. 10 mg Features
Figure 5. 140 mg Features
Figure 6. Global Imbruvica Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Imbruvica Market Share by Application: 2023 VS 2030
Figure 8. Mantle Cell Lymphoma Case Studies
Figure 9. Chronic Lymphocytic Leukemia Case Studies
Figure 10. Waldenström's Macroglobulinemia Case Studies
Figure 11. Relapsed/Refractory Marginal Zone Lymphoma Case Studies
Figure 12. Chronic Graft-Versus-Host-Disease Case Studies
Figure 13. Imbruvica Report Years Considered
Figure 14. Global Imbruvica Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Imbruvica Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Imbruvica Market Share by Region: 2023 VS 2030
Figure 17. Global Imbruvica Market Share by Players in 2023
Figure 18. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Imbruvica Revenue in 2023
Figure 20. North America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Imbruvica Market Share by Country (2019-2030)
Figure 22. United States Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Imbruvica Market Share by Country (2019-2030)
Figure 26. Germany Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Imbruvica Market Share by Region (2019-2030)
Figure 34. China Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Imbruvica Market Share by Country (2019-2030)
Figure 42. Mexico Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Imbruvica Market Share by Country (2019-2030)
Figure 46. Turkey Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. AbbVie (Pharmacyclics) Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 49. Johnson & Johnson (Janssen Biotech) Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 50. SP Laboratories Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Imbruvica Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 5 mg
Table 3. Key Players of 10 mg
Table 4. Key Players of 140 mg
Table 5. Global Imbruvica Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Imbruvica Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Imbruvica Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Imbruvica Market Share by Region (2019-2024)
Table 9. Global Imbruvica Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Imbruvica Market Share by Region (2025-2030)
Table 11. Imbruvica Market Trends
Table 12. Imbruvica Market Drivers
Table 13. Imbruvica Market Challenges
Table 14. Imbruvica Market Restraints
Table 15. Global Imbruvica Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Imbruvica Market Share by Players (2019-2024)
Table 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
Table 18. Ranking of Global Top Imbruvica Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Imbruvica Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Imbruvica Product Solution and Service
Table 22. Date of Enter into Imbruvica Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Imbruvica Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Imbruvica Revenue Market Share by Type (2019-2024)
Table 26. Global Imbruvica Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Imbruvica Revenue Market Share by Type (2025-2030)
Table 28. Global Imbruvica Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Imbruvica Revenue Market Share by Application (2019-2024)
Table 30. Global Imbruvica Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Imbruvica Revenue Market Share by Application (2025-2030)
Table 32. North America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Imbruvica Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Imbruvica Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Imbruvica Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Imbruvica Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Imbruvica Market Size by Country (2025-2030) & (US$ Million)
Table 47. AbbVie (Pharmacyclics) Company Detail
Table 48. AbbVie (Pharmacyclics) Business Overview
Table 49. AbbVie (Pharmacyclics) Imbruvica Product
Table 50. AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 51. AbbVie (Pharmacyclics) Recent Development
Table 52. Johnson & Johnson (Janssen Biotech) Company Detail
Table 53. Johnson & Johnson (Janssen Biotech) Business Overview
Table 54. Johnson & Johnson (Janssen Biotech) Imbruvica Product
Table 55. Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson (Janssen Biotech) Recent Development
Table 57. SP Laboratories Company Detail
Table 58. SP Laboratories Business Overview
Table 59. SP Laboratories Imbruvica Product
Table 60. SP Laboratories Revenue in Imbruvica Business (2019-2024) & (US$ Million)
Table 61. SP Laboratories Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imbruvica Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Imbruvica Market Share by Type: 2023 VS 2030
Figure 3. 5 mg Features
Figure 4. 10 mg Features
Figure 5. 140 mg Features
Figure 6. Global Imbruvica Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Imbruvica Market Share by Application: 2023 VS 2030
Figure 8. Mantle Cell Lymphoma Case Studies
Figure 9. Chronic Lymphocytic Leukemia Case Studies
Figure 10. Waldenström's Macroglobulinemia Case Studies
Figure 11. Relapsed/Refractory Marginal Zone Lymphoma Case Studies
Figure 12. Chronic Graft-Versus-Host-Disease Case Studies
Figure 13. Imbruvica Report Years Considered
Figure 14. Global Imbruvica Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Imbruvica Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Imbruvica Market Share by Region: 2023 VS 2030
Figure 17. Global Imbruvica Market Share by Players in 2023
Figure 18. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Imbruvica Revenue in 2023
Figure 20. North America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Imbruvica Market Share by Country (2019-2030)
Figure 22. United States Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Imbruvica Market Share by Country (2019-2030)
Figure 26. Germany Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Imbruvica Market Share by Region (2019-2030)
Figure 34. China Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Imbruvica Market Share by Country (2019-2030)
Figure 42. Mexico Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Imbruvica Market Share by Country (2019-2030)
Figure 46. Turkey Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. AbbVie (Pharmacyclics) Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 49. Johnson & Johnson (Janssen Biotech) Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 50. SP Laboratories Revenue Growth Rate in Imbruvica Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232